MedTrace Logo

NAG-excretion During Cardiopulmonary Bypass

NCT02410642 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2016-03-08

No results posted yet for this study

Summary

NAG is a protein excreted in urine in cases of tubular damage, and is considered a biomarker of kidney injury. Elevated urinary NAG is seen after cardiac surgery, but the clinical significance, pattern of excretion and links to perioperative factors are poorly described. We plan a study of the pattern of NAG-excretion during cardiac surgery with cardiopulmonary bypass, and explore possible associated variables.

Conditions

  • Renal Impairment

Interventions

PROCEDURE

cardiopulmonary bypass

Routine use of cardiopulmonary bypass as needed during cardiac surgery

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02410642 on ClinicalTrials.gov